Tag: NASDAQ:ALLO

Allogene Therapeutics Inc’s filing revealed that its Officer Douglas Earl Martin acquired Company’s shares for reported $78844.0 on Aug 21

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or